The article presents a comparative analysis of SARS-CoV-2 viral load (VL), T lymphocyte count and respiratory index PaO 2 :FiO 2 ratio as prospective markers of COVID-19 course severity and prognosis. 8806 patients and asymptomatic carriers were investigated in time interval 15 March–19 December 2020. T cell count demonstrated better applicability as a marker of aggravating COVID-19 clinical course and unfavourable disease prognosis than SARS-CoV-2 VL or PaO 2 :FiO 2 ratio taken alone. Using T cell count in clinical practice may provide an opportunity of early prediction of deteriorating a patient’s state.
All Keywords
【저자키워드】 Infectious diseases, Signs and symptoms, 【초록키워드】 COVID-19, SARS-CoV-2, Prognosis, Asymptomatic carrier, T cell, Clinical course, Patient, disease, Clinical practice, marker, Analysis, SARS-CoV-2 viral load, T lymphocyte, applicability, Course, investigated, demonstrated, PaO, severity and prognosis, 【제목키워드】 COVID-19, severity, T cell, Clinical course, Patient, marker, SARS-CoV-2 viral load,
【저자키워드】 Infectious diseases, Signs and symptoms, 【초록키워드】 COVID-19, SARS-CoV-2, Prognosis, Asymptomatic carrier, T cell, Clinical course, Patient, disease, Clinical practice, marker, Analysis, SARS-CoV-2 viral load, T lymphocyte, applicability, Course, investigated, demonstrated, PaO, severity and prognosis, 【제목키워드】 COVID-19, severity, T cell, Clinical course, Patient, marker, SARS-CoV-2 viral load,